A mixture of droloxifene isomers
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(E/Z)-Droloxifene

Item No. 33406

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol
CAS Number
165813-01-4
Synonyms
  • 3-Hydroxytamoxifen
Molecular Formula
C26H29NO2
Formula Weight
387.5
Purity
≥98% (mixture of isomers)
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMF:PBS (pH 7.2) (1:3): 0.25 mg/mlDMSO: 15 mg/mlEthanol: 1 mg/ml
SMILES
CCC(C1=CC=CC=C1)=C(C2=CC(O)=CC=C2)C3=CC=C(C=C3)OCCN(C)C
InChi Code
InChI=1S/C26H29NO2/c1-4-25(20-9-6-5-7-10-20)26(22-11-8-12-23(28)19-22)21-13-15-24(16-14-21)29-18-17-27(2)3/h5-16,19,28H,4,17-18H2,1-3H3
InChi Key
ZQZFYGIXNQKOAV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $82

    Add

    10 mg

    $130

    Add

    25 mg

    $183

    Add

    50 mg

    $322

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    (E/Z)-Droloxifene is a mixture of (E)-droloxifene, a selective estrogen receptor modulator (SERM), and (Z)-droloxifene.1 (E)-Droloxifene binds to the estrogen receptor (ER) in rabbit uterine homogenates (IC50 = 24 nM in a radioligand binding assay), increases uterine weight in immature rats, and reduces estradiol-induced increases in uterine weight in juvenile rats.1,2,3 It also inhibits 17β-estradiol-stimulated growth of MCF-7, ZR-75-1, and T47D human breast cancer cells in a concentration-dependent manner.4 (Z)-Droloxifene binds weakly to ERs and has no estrogenic or antiestrogenic activity.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Robertson, J.F.R. Selective oestrogen receptor modulators/new antioestrogens: A clinical perspective. Cancer Treat. Rev. 30(8), 695-706 (2004).

    2. Löser, R., Seibel, K., Roos, W., et al. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen. Eur. J. Cancer Clin. Oncol. 21(8), 985-990 (1985).

    3. Hasmann, M., Rattel, B., and Löser, R. Preclinical data for droloxifene. Cancer Lett. 84(2), 101-116 (1994).

    4. Kawamura, I., Mizota, T., Lacey, E., et al. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers. Jpn. J. Pharmacol. 63(1), 27-34 (1993).

    5. Löser, R., Seibel, K., and Huber, H.J. Pharmacological activities of droloxifene isomers. Anticancer Res. 8(6), 1271-1274 (1988).